{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T17:18:55Z","timestamp":1770743935193,"version":"3.49.0"},"reference-count":99,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T00:00:00Z","timestamp":1666656000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Leukemia &amp; Lymphoma"],"published-print":{"date-parts":[[2023,1,2]]},"DOI":"10.1080\/10428194.2022.2131423","type":"journal-article","created":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T16:36:23Z","timestamp":1666715783000},"page":"30-41","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["Treatment of relapsed and refractory Waldenstrom Macroglobulinemia"],"prefix":"10.1080","volume":"64","author":[{"given":"Karima","family":"Amaador","sequence":"first","affiliation":[{"name":"Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8904-3802","authenticated-orcid":false,"given":"Marie J.","family":"Kersten","sequence":"additional","affiliation":[{"name":"Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3139-8379","authenticated-orcid":false,"given":"Monique C.","family":"Minnema","sequence":"additional","affiliation":[{"name":"Department of Hematology, University Medical Center Utrecht, University Utrecht, Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josephine M. I.","family":"Vos","sequence":"additional","affiliation":[{"name":"Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2022,10,25]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2018.02.011"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2012.656103"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17856"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-643569"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25254"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14743"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/815325"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000725"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-01-553974"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy146"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.4065\/mcp.2010.0304"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2016.08.024"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1200710"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-01102-3"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-01-550905"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.71.0814"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15560"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-0007"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-09-525808"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-04-711234"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(18)30087-5"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(20)30224-6"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14826"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.9.2640"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-018-3311-z"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2015.1012714"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.3816\/CLML.2011.n.030"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-140774"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.23.6315"},{"key":"CIT0030","doi-asserted-by":"crossref","unstructured":"Tedeschi A, Benevolo G, Varettoni M, Battista ML, Zinzani PL, Visco C, et al. Fludarabine plus cyclophosphamide and rituximab in Waldenstrom macroglobulinemia: an effective but myelosuppressive regimen to be offered to patients with advanced disease. Cancer. 2012;118(2):434\u201343.","DOI":"10.1002\/cncr.26303"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2013.02.011"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24405"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2016.1233541"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-2511"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.07.8659"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.25.3237"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2017.1307357"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.00105"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-03-566273"},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2017.1321749"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1501548"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30632-5"},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1802917"},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(19)30210-8"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020006449"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020006844"},{"key":"CIT0047","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-21-0539"},{"key":"CIT0048","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003010"},{"key":"CIT0049","doi-asserted-by":"publisher","DOI":"10.1111\/cas.14561"},{"key":"CIT0050","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-149350"},{"key":"CIT0051","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.01194"},{"key":"CIT0052","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003895"},{"issue":"20","key":"CIT0053","first-page":"5089","volume":"4","author":"Castillo JJ","year":"2020","journal-title":"Blood Adv"},{"key":"CIT0054","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021012953"},{"key":"CIT0055","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2011.03.004"},{"key":"CIT0056","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2010.218"},{"key":"CIT0057","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-03-342485"},{"key":"CIT0058","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2011.158"},{"key":"CIT0059","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-05-503862"},{"key":"CIT0060","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V126.23.1833.1833"},{"key":"CIT0061","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0172996"},{"key":"CIT0062","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)71125-8"},{"key":"CIT0063","unstructured":"Covey T, Barf T, Gulrajani M, et\u00a0al."},{"key":"CIT0064","unstructured":"Roger Owen HM, Rule S, D'Sa S, et\u00a0al. Acalabrutinib in treatment-naive or relapsed\/refractory Waldenstr\u00f6m macroglobulinemia: 5-year follow-up of a phase 2, Single-Arm Study. EHA 20222022."},{"key":"CIT0065","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2022.40.16_suppl.7521"},{"key":"CIT0066","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-01-761726"},{"key":"CIT0067","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00224-5"},{"key":"CIT0068","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703041"},{"key":"CIT0069","doi-asserted-by":"publisher","DOI":"10.1053\/sonc.2003.50048"},{"key":"CIT0070","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2006.04.010"},{"key":"CIT0071","doi-asserted-by":"publisher","DOI":"10.1179\/102453308X315915"},{"key":"CIT0072","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.24.4905"},{"key":"CIT0073","first-page":"2026","volume":"130","author":"Kyriakou C","year":"2017","journal-title":"Blood"},{"key":"CIT0074","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2016.10.010"},{"key":"CIT0075","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.27.3607"},{"key":"CIT0076","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2016.5763"},{"key":"CIT0077","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12760"},{"key":"CIT0078","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-02-005488"},{"key":"CIT0079","unstructured":"NIH. Ibrutinib\u2009+\u2009Venetoclax in Untreated WM. 2020. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04273139"},{"key":"CIT0080","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-2333"},{"key":"CIT0081","unstructured":"NIH. A study of ulocuplumab and ibrutinib in symptomatic patients with mutated CXCR4 Waldenstrom\u2019s macroglobulinemia. https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT03225716"},{"key":"CIT0082","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-144706"},{"key":"CIT0083","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2021.2018584"},{"key":"CIT0084","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1607751"},{"key":"CIT0085","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1506348"},{"key":"CIT0086","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-01-763599"},{"key":"CIT0087","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2022.2030478"},{"key":"CIT0088","doi-asserted-by":"publisher","DOI":"10.1007\/s12254-018-0409-x"},{"issue":"1","key":"CIT0089","first-page":"40","volume":"136","author":"Jacobson C","year":"2020","journal-title":"Blood"},{"key":"CIT0090","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-004128"},{"key":"CIT0091","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-122451"},{"key":"CIT0092","unstructured":"Daratumumab plus ibrutinib in patients with Waldenstr\u00f6m\u2019s macroglobulinemia. https:\/\/ClinicalTrials.gov\/show\/NCT03679624"},{"key":"CIT0093","unstructured":"Ibrutinib and ixazomib citrate in treating patients with newly diagnosed, relapsed or refractory Waldenstrom Macroglobulinemia. https:\/\/ClinicalTrials.gov\/show\/NCT03506373"},{"key":"CIT0094","unstructured":"Loncastuximab Tesirine in WM. https:\/\/ClinicalTrials.gov\/show\/NCT05190705"},{"key":"CIT0095","unstructured":"Study of Iopofosine I 131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) and pivotal expansion in Waldenstrom Macroglobulinemia. https:\/\/ClinicalTrials.gov\/show\/NCT02952508"},{"key":"CIT0096","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.00555"},{"key":"CIT0097","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1506192"},{"key":"CIT0098","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-150154"},{"issue":"7","key":"CIT0099","first-page":"EVIDoa2200006","volume":"1","author":"Kater Arnon P","year":"2022","journal-title":"NEJM Evidence"}],"container-title":["Leukemia &amp; Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10428194.2022.2131423","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,2]],"date-time":"2023-04-02T03:23:37Z","timestamp":1680405817000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10428194.2022.2131423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,25]]},"references-count":99,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1,2]]}},"alternative-id":["10.1080\/10428194.2022.2131423"],"URL":"https:\/\/doi.org\/10.1080\/10428194.2022.2131423","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,25]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-07-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-03","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}